John M. L. Ebos

Molecular Biology · 2009–2014

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom John M. L. Ebos trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Bergers
  2. D. Hanahan
  3. D. Nguyen

Who trusts John M. L. Ebos overall

  1. N. Vasudev
  2. G. Semenza
  3. Peter Carmeliet
  4. Sébastien Benzekry
  5. Zhenling Liu
  6. C. Viallard
  7. Bryan L. Krock
  8. Andrew R Reynolds

Papers from John M. L. Ebos's perspective

Ordered by how strongly the researchers John M. L. Ebos trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. (Cancer Cell)
  2. Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
  3. Metastasis: from dissemination to organ-specific colonization (Nature Reviews. Cancer)
  4. Model selection and multimodel inference : a practical information-theoretic approach
  5. Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (Cancer Cell)
  6. Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting.ByHarvey Motulskyand, Arthur Christopoulos.Oxford and New York: Oxford University Press.…
  7. A general model for ontogenetic growth (Nature)
  8. Deciphering death: a commentary on Gompertz (1825) ‘On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies’ (Philosophical Transactions of the Royal Society B: Biological Sciences)
  9. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
  10. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)

Their papers